In summary, these result show that in multiple HER2+ and/or EGFR+ breast cancer cell lines EGF selectively enables and/or potentiates activation of a subset of critical TGFβ-SMAD inducible invasion/migration-associated genes. The gene discussed is ERBB2; the disease is breast cancer.